Lloyd DG - Search Results

1

Ethyl side-chain modifications in novel flexible antiestrogens--design, synthesis and biological efficacy in assay against the MCF-7 breast tumor cell line.

Meegan MJ, Hughes RB, Lloyd DG, Williams DC, Zisterer DM. Meegan MJ, et al. Among authors: lloyd dg. Anticancer Drug Des. 2001 Feb;16(1):57-69. Anticancer Drug Des. 2001. PMID: 11762645

2

Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor.

Lloyd DG, Hughes RB, Zisterer DM, Williams DC, Fattorusso C, Catalanotti B, Campiani G, Meegan MJ. Lloyd DG, et al. J Med Chem. 2004 Nov 4;47(23):5612-5. doi: 10.1021/jm0495834. J Med Chem. 2004. PMID: 15509159

3

Antiestrogenically active 2-benzyl-1,1-diarylbut-2-enes: synthesis, structure-activity relationships and molecular modeling study for flexible estrogen receptor antagonists.

Lloyd DG, Smith HM, O'Sullivan T, Knox AS, Zisterer DM, Meegan MJ. Lloyd DG, et al. Med Chem. 2006 Mar;2(2):147-68. doi: 10.2174/157340606776056142. Med Chem. 2006. PMID: 16787364

4

Synthesis, structure-activity relationships and antagonistic effects in human MCF-7 breast cancer cells of flexible estrogen receptor modulators.

Lloyd DG, Smith HM, O'Sullivan T, Zisterer DM, Meegan MJ. Lloyd DG, et al. Med Chem. 2005 Jul;1(4):335-53. doi: 10.2174/1573406054368666. Med Chem. 2005. PMID: 16789891

5

Flexible estrogen receptor modulators: synthesis, biochemistry and molecular modeling studies for 3-benzyl-4,6-diarylhex-3-ene and 3,4,6-triarylhex-3-ene derivatives.

Smith HM, Knox AJ, Zisterer DM, Lloyd DG, Meegan MJ. Smith HM, et al. Among authors: lloyd dg. Med Chem. 2007 Mar;3(2):135-55. doi: 10.2174/157340607780059503. Med Chem. 2007. PMID: 17348852

6

Target specific virtual screening: optimization of an estrogen receptor screening platform.

Knox AJ, Meegan MJ, Sobolev V, Frost D, Zisterer DM, Williams DC, Lloyd DG. Knox AJ, et al. Among authors: lloyd dg. J Med Chem. 2007 Nov 1;50(22):5301-10. doi: 10.1021/jm0700262. Epub 2007 Oct 5. J Med Chem. 2007. PMID: 17918820

7

Benzothiepin-derived molecular scaffolds for estrogen receptor modulators: synthesis and antagonistic effects in breast cancer cells.

Meegan MJ, Barrett I, Zimmermann J, Knox AJ, Zisterer DM, Lloyd DG. Meegan MJ, et al. Among authors: lloyd dg. J Enzyme Inhib Med Chem. 2007 Oct;22(5):655-66. doi: 10.1080/14756360701503232. J Enzyme Inhib Med Chem. 2007. PMID: 18035834 Free article.

8

Beta-lactam type molecular scaffolds for antiproliferative activity: synthesis and cytotoxic effects in breast cancer cells.

Meegan MJ, Carr M, Knox AJ, Zisterer DM, Lloyd DG. Meegan MJ, et al. Among authors: lloyd dg. J Enzyme Inhib Med Chem. 2008 Oct;23(5):668-85. doi: 10.1080/14756360802469127. J Enzyme Inhib Med Chem. 2008. PMID: 18821256 Free article.

9

Synthesis, biological evaluation, structural-activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators.

Barrett I, Meegan MJ, Hughes RB, Carr M, Knox AJ, Artemenko N, Golfis G, Zisterer DM, Lloyd DG. Barrett I, et al. Among authors: lloyd dg. Bioorg Med Chem. 2008 Nov 1;16(21):9554-73. doi: 10.1016/j.bmc.2008.09.035. Epub 2008 Sep 16. Bioorg Med Chem. 2008. PMID: 18835176

10

Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.

Carr M, Greene LM, Knox AJ, Lloyd DG, Zisterer DM, Meegan MJ. Carr M, et al. Among authors: lloyd dg. Eur J Med Chem. 2010 Dec;45(12):5752-66. doi: 10.1016/j.ejmech.2010.09.033. Epub 2010 Sep 22. Eur J Med Chem. 2010. PMID: 20933304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

315 results

Search Page

Filters